We are live on ! Find out more
TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+18.15%
3 Year Est. Return
+62.51%
5 Year Est. Return
+140.53%
10 Year Est. Return
+502.91%
AUM
$3.08B
AUM Growth
+$170M
Cap. Flow
-$43.5M
Cap. Flow %
-1.41%
Top 10 Hldgs %
31.64%
Holding
198
New
2
Increased
42
Reduced
41
Closed
9

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$41.2M
2
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$21.9M
3
UTHR icon
United Therapeutics
UTHR
+$14.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$12.5M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$11.5M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$21.8M
2
STE icon
Steris
STE
+$20M
3
ILMN icon
Illumina
ILMN
+$18.6M
4
WAT icon
Waters Corp
WAT
+$17.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 95.67%
2 Real Estate 2.94%
3 Industrials 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
151
DELISTED
KalVista Pharmaceuticals
KALV
$2.4M 0.08%
100,000
+50,000
+100% +$1.31M
PRGO icon
152
Perrigo
PRGO
$1.43B
$2.35M 0.08%
51,224
– –
SNR
153
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$2.25M 0.07%
256,398
– –
HOLX
154
DELISTED
Hologic
HOLX
$2.17M 0.07%
32,564
– –
HR icon
155
Healthcare Realty
HR
$7.46B
$1.89M 0.06%
70,662
– –
VECT
156
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$1.69M 0.06%
+145,000
New +$2.2M
OGN icon
157
Organon & Co
OGN
$3.56B
$1.64M 0.05%
+54,169
New +$1.78M
BDTX icon
158
Black Diamond Therapeutics
BDTX
$98.6M
$1.61M 0.05%
131,990
– –
MOR
159
DELISTED
MorphoSys AG American Depositary Shares
MOR
$1.58M 0.05%
81,867
– –
CYH icon
160
Community Health Systems
CYH
$391M
$1.57M 0.05%
101,535
-16,000
-14% -$217K
MTEM
161
DELISTED
Molecular Templates, Inc.
MTEM
$1.56M 0.05%
13,295
– –
ICPT
162
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.54M 0.05%
77,067
– –
ZGNX
163
DELISTED
Zogenix, Inc.
ZGNX
$1.54M 0.05%
88,977
– –
DHC
164
Diversified Healthcare Trust
DHC
$2.17B
$1.5M 0.05%
357,720
– –
OVID icon
165
Ovid Therapeutics
OVID
$442M
$1.46M 0.05%
372,733
– –
PRAX icon
166
Praxis Precision Medicines
PRAX
$8.58B
$1.37M 0.04%
5,000
– –
MDGL icon
167
Madrigal Pharmaceuticals
MDGL
$11.4B
$1.3M 0.04%
13,340
– –
CCXI
168
DELISTED
ChemoCentryx, Inc.
CCXI
$1.05M 0.03%
78,197
-66,250
-46% -$1.63M
ONEM
169
DELISTED
1Life Healthcare
ONEM
$1.03M 0.03%
31,266
– –
NKTX icon
170
Nkarta
NKTX
$154M
$919K 0.03%
28,988
– –
TFX icon
171
Teleflex
TFX
$5.86B
$884K 0.03%
2,200
– –
EDIT icon
172
Editas Medicine
EDIT
$413M
$860K 0.03%
15,190
– –
RGNX icon
173
Regenxbio
RGNX
$648M
$843K 0.03%
21,700
– –
GRFS
174
Grifois
GRFS
$5.58B
$822K 0.03%
47,373
– –
DTIL icon
175
Precision BioSciences
DTIL
$181M
$789K 0.03%
2,100
– –
4 5 6
7
8

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
BWM
BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

Tekla Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Tekla Capital Management held 198 positions worth $3.08B, up 5.9% from $2.91B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tekla Capital Management's Q2 2021 filing shows 2 new, 42 increased, 41 reduced and 9 closed positions. Its largest new stake was VectivBio Holding AG Ordinary Shares: 145,000 shares worth $1.69M. The largest sale was Elevance Health, an estimated $21.8M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Real Estate and Industrials.

  • Tekla Capital Management's largest Q2 2021 buy was VectivBio Holding AG Ordinary Shares: 145,000 shares worth $1.69M.
  • Tekla Capital Management added most to UnitedHealth in Q2 2021, an estimated $41.2M increase.
  • Tekla Capital Management's biggest Q2 2021 reduction was Elevance Health, cutting an estimated $21.8M.
  • Tekla Capital Management fully exited Morphic Holding, Inc. Common Stock in Q2 2021, selling an estimated $5.67M.
  • Tekla Capital Management's ten largest holdings make up 32% of its $3.08B portfolio in Q2 2021.
  • Tekla Capital Management opened 2 new positions and closed 9 in Q2 2021.
  • Tekla Capital Management's portfolio value rose 5.9% quarter-over-quarter to $3.08B.

Based on Tekla Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.